Bionik Laboratories Corp. is a robotics company providing neurological functional recovery solutions to improve the quality of life of millions of people with functional or mobility impairments by combining artificial intelligence, innovative technology and data solutions to help individuals regain mobility, enhance autonomy, and regain self-esteem.
Company profile
Ticker
BNKL
Exchange
Website
CEO
Eric Michel Dusseux
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • INVACARE • Align Technology • Surgalign ...
Former names
Drywave Technologies, Inc., Strategic Dental Management Corp.
SEC CIK
Corporate docs
IRS number
271340346
BNKL stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
30 Jun 23
8-K
Departure of Directors or Certain Officers
27 Jun 23
10-K
2023 FY
Annual report
21 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jun 23
8-K
Entry into a Material Definitive Agreement
16 Jun 23
8-K
Unregistered Sales of Equity Securities
16 Jun 23
8-K
Bionik Laboratories Expands its Partnership with Lifepoint Health with the Installation of InMotion® Robotic Devices at Four New Locations
15 Jun 23
SD
Conflict minerals disclosure
31 May 23
8-K
Bionik Laboratories Reports a Significant Increase in Patient Volume at its Acquired
23 May 23
8-K
Bionik Laboratories Enters into Distribution Agreement with Pro-Med Technology for the Sale of InMotion® Robotic Devices in Hong Kong
4 May 23
Latest ownership filings
4
Remi Gaston-Dreyfus
21 Jun 23
4
ANDRE-JACQUES AUBERTON-HERVE
21 Jun 23
4
Charles Matine
21 Jun 23
4
Remi Gaston-Dreyfus
21 Jun 23
4
ANDRE-JACQUES AUBERTON-HERVE
21 Jun 23
3
Daniel Gonsalves
25 Oct 22
4
Richard Paul Russo Jr
13 Oct 22
4
ANDRE-JACQUES AUBERTON-HERVE
21 Jun 22
4
Remi Gaston-Dreyfus
21 Jun 22
4
Remi Gaston-Dreyfus
13 Dec 21
Financial summary
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 427.38 k | 427.38 k | 427.38 k | 427.38 k | 427.38 k | 427.38 k |
Cash burn (monthly) | 85.94 k | 130.33 k | 432.37 k | 402.09 k | 252.31 k | 282.28 k |
Cash used (since last report) | 1.10 mm | 1.66 mm | 5.52 mm | 5.13 mm | 3.22 mm | 3.60 mm |
Cash remaining | -669.49 k | -1.24 mm | -5.09 mm | -4.70 mm | -2.79 mm | -3.18 mm |
Runway (months of cash) | -7.8 | -9.5 | -11.8 | -11.7 | -11.1 | -11.2 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jun 23 | Gaston-Dreyfus Remi | Common Stock, par value $0.001 per share | Conversion | Acquire C | Yes | No | 0.6 | 3,102,878 | 1.86 mm | 4,917,749 |
13 Jun 23 | Auberton-herve Andre-jacques | Common Stock | Conversion | Acquire C | Yes | No | 0.6 | 186,111 | 111.67 k | 1,109,271 |
13 Jun 23 | Auberton-herve Andre-jacques | Convertible Promissory Note Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 220000 | 1 | 220.00 k | 1 |
9 Jun 23 | Auberton-herve Andre-jacques | Common Stock | Buy | Acquire P | Yes | No | 0.6 | 650,000 | 390.00 k | 923,160 |
9 Jun 23 | Gaston-Dreyfus Remi | Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 0.6 | 180,555 | 108.33 k | 1,814,871 |
9 Jun 23 | Charles Matine | Common Stock, par value $0.001 per share | Buy | Acquire P | No | No | 0.6 | 180,555 | 108.33 k | 206,985 |